Global Urinalysis Market Driven by Increasing Burden of UTIs, Diabetes, and Kidney & Liver Diseases

The global urinalysis market is projected to reach USD 4.9 billion by 2026, driven by the increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests. Additionally, growth avenues in the emerging economies will provide lucrative opportunities for the players operating in the urinalysis market. These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a market research firm.

The rising geriatric population in the world’s developed and developing regions will positively influence the growth of the global urinalysis market. Due to the rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes, liver, and kidney diseases is expected to increase significantly. The need for diagnosis and management of such diseases is responsible for the increasing number of prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin, etc. These tests are performed by urinalysis and hence, are expected to have a positive impact on the urinalysis market.

However, the availability of refurbished devices could hamper the growth of the urinalysis market as these instruments offer the same functionalities as new equipment at a lower cost. Several end users, mainly small and medium-sized laboratories, opt for cost-effective and refurbished devices. In particular, the markets in developing countries, which are price-sensitive, prefer devices that are cheap and offer similar functionalities. In the absence of well-grounded regulatory frameworks, there could be an influx of low-quality and refurbished urine analyzers into the market. Considering these factors, the demand for refurbished urine analyzers can be expected to increase in the coming years, as these systems offer the same functionalities at a lower cost. This is expected to hamper the revenues of companies offering branded urine analyzers, and thus restrain the overall market growth.

Based on product, the consumables segment accounted for the largest share of the urinalysis market due to frequent purchase of these products on account of their recurrent usage. Based on test type, the sediment urinalysis segment is recording the fastest growth due to the increasing adoption of automated devices for sediment analysis. Based on application, the disease screening segment held the largest share of the urinalysis market due to the increasing incidence of UTIs, diabetes, liver diseases and kidney ailments worldwide. Based on end user, the diagnostic laboratories segment accounted for the largest share of the urinalysis market, owing to the rapidly growing aging population, increasing global incidence of kidney diseases and UTIs, rise in reimbursements for clinical tests performed in hospitals, and launch of advanced urinalysis devices such as integrated devices. Geographically, North America held the largest share of the global urinalysis market owing to the growing geriatric population, favorable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and availability of technologically advanced instruments in the region.

Related Links:
MarketsandMarkets

Visit expo >

Gold Member

Serological Pipet Controller

PIPETBOY GENIUS

Verification Panels for Assay Development & QC
Seroconversion Panels

New

Vaginitis Test

Allplex Vaginitis Screening Assay

New

Silver Member

Verification Panels for Assay Development & QC

Seroconversion Panels